MAPT and Alzheimer disease: During pathological conditions, such as Alzheimer's disease (AD), microglia can shift from an anti-inflammatory (M2) state to a pro-inflammatory (M1) state, releasing cytokines and promoting synaptic loss, Tau phosphorylation, and memory loss.